CAPLIPOINT — Caplin Point Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Caplin Point Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10,613	12,694	14,667	16,941	19,375
Cost of Revenue
Gross Profit	5,698	6,876	7,719	9,312	11,666
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,690	9,213	10,700	11,952	13,565
Operating Profit	2,923	3,481	3,968	4,989	5,810
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,136	3,858	4,514	5,644	6,768
Provision for Income Taxes
Net Income After Taxes	2,514	3,085	3,770	4,614	5,411
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,423	2,998	3,763	4,571	5,363
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,423	2,998	3,763	4,571	5,363
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	31.8	39.2	49.2	60	70.3
Dividends per Share